Cargando…
Sphingosine 1-phosphate receptor 2 (S1P(2)) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy
Ototoxic drugs, such as platinum-based chemotherapeutics, often lead to permanent hearing loss through apoptosis of neuroepithelial hair cells and afferent neurons of the cochlea. There is no approved therapy for preventing or reversing this process. Our previous studies identified a G protein-coupl...
Autores principales: | Herr, Deron R., Reolo, Marie J. Y., Peh, Yee Xin, Wang, Wei, Lee, Chang-Wook, Rivera, Rich, Paterson, Ian C., Chun, Jerold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832229/ https://www.ncbi.nlm.nih.gov/pubmed/27080739 http://dx.doi.org/10.1038/srep24541 |
Ejemplares similares
-
Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment
por: Wang, Wei, et al.
Publicado: (2020) -
Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021) -
The Use of Nanoparticles in Otoprotection
por: Barbara, Maurizio, et al.
Publicado: (2022) -
Persistence of the otoprotective effect. How long does otoprotection against amikacin lasts?
por: de Oliveira, Andreia Ardevino, et al.
Publicado: (2015) -
Inhibition of sphingosine‐1‐phosphate receptor 2 attenuated ligature‐induced periodontitis in mice
por: Snipes, Marquise, et al.
Publicado: (2020)